03320

China Resources Pharmaceutical G…

4.95

-0.06-1.20%

Closed16:08 05/13 HKT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE5.030/5.010

TODAY RANGE4.940-5.050

VOL9.61M

MARKET CAP31.10B

52 WEEK RANGE4.610-7.110

AVG VOL (3M)13.81M

% TURNOVER0.15%

TURNOVER47.74M

P/E (TTM)8.594

% RANGE2.20%

EPS(TTM)0.576

P/E(FORWARD)7.138

P/B0.597

BVPS8.292

DIVIDEND0.147

P/S0.122

BETA--

DIV YIELD2.97%

FREE FLOAT MKT CAP31.10B

SHARES OUTSTANDING6.28B

NEXT EARNINGS08/27-09/01

FREE FLOAT6.28B

LOT SIZE500

EX-DIV DATE05/28/2025

News

Press Releases

Financial Reports

Profile

Simply Wall St·04/30 23:21
China Resources Pharmaceutical Group Full Year 2024 Earnings: Misses Expectations
Simply Wall St·03/28 23:55
Earnings Miss: China Resources Pharmaceutical Group Limited Missed EPS By 21% And Analysts Are Revising Their Forecasts
Simply Wall St·03/27 23:47
Calculating The Intrinsic Value Of China Resources Pharmaceutical Group Limited (HKG:3320)
Reuters·03/26 04:03
CHINA RESOURCES PHARMACEUTICAL GROUP FY REVENUE RMB 257,673.3 MILLION
Reuters·03/26 04:03
CHINA RESOURCES PHARMACEUTICAL GROUP FY GROSS PROFIT RMB 40,688.9 MILLION
Simply Wall St·02/11 01:36
China Resources Pharmaceutical Group Limited's (HKG:3320) Shares May Have Run Too Fast Too Soon
Simply Wall St·12/19/2024 00:32
Does China Resources Pharmaceutical Group (HKG:3320) Have A Healthy Balance Sheet?
Reuters·11/26/2024 12:43
PFIZER INVESTMENT: SIGNS STRATEGIC PARTNERSHIP WITH CHINA RESOURCES PHARMACEUTICAL COMMERCIAL GROUP TO JOINTLY COMMERCIALIZE FOUR KEY DRUGS FOR BREAST AND LUNG CANCER
Simply Wall St·11/13/2024 01:03
China Resources Pharmaceutical Group (HKG:3320) shareholders have earned a 20% CAGR over the last three years
Simply Wall St·10/07/2024 22:30
China Resources Pharmaceutical Group Limited's (HKG:3320) Shares Climb 34% But Its Business Is Yet to Catch Up
Simply Wall St·08/30/2024 23:03
Here's Why China Resources Pharmaceutical Group (HKG:3320) Can Manage Its Debt Responsibly
Simply Wall St·07/23/2024 23:35
China Resources Pharmaceutical Group (HKG:3320) shareholders have endured a 27% loss from investing in the stock five years ago
Simply Wall St·06/01/2024 00:09
China Resources Pharmaceutical Group (HKG:3320) Is Increasing Its Dividend To CN¥0.1697
Simply Wall St·05/13/2024 22:24
Subdued Growth No Barrier To China Resources Pharmaceutical Group Limited (HKG:3320) With Shares Advancing 32%

Same Industry

Name/Symbol

Change%

Price

China Resources Pharmaceutical Group

03320

-1.20%

4.950

Amgen

04332

Asymchem Laboratories (Tianjin)

06821

+1.40%

54.450

Wuxi Apptec

02359

-0.64%

62.400

China Conch Venture Holdings

00586

-1.53%

7.700

Sinopharm Group

01099

-1.07%

18.420

Guangzhou Baiyunshan Pharmaceutical Holdings

00874

-0.93%

17.020

Livzon Pharmaceutical Group

01513

-0.19%

26.150

Shanghai Pharmaceuticals Holding

02607

-1.78%

11.020

Shanghai Fosun Pharmaceutical (Group)

02196

-1.14%

13.920

China Medical System Holdings

00867

-0.97%

8.160

SciClone Pharmaceuticals (Holdings)

06600

0.00%

18.720

Wuxi Biologics (Cayman)

02269

-0.43%

23.150

China Isotope & Radiation

01763

-0.34%

11.620

China Shineway Pharmaceutical Group

02877

-1.11%

7.140

The United Laboratories International Holdings

03933

+2.03%

13.040

Consun Pharmaceutical Group

01681

+0.21%

9.440

3SBio

01530

+2.50%

11.500

Shandong Xinhua Pharmaceutical

00719

-0.35%

5.690

Beijing Tong Ren Tang Chinese Medicine

03613

-1.28%

8.480

CSPC Pharmaceutical Group

01093

+0.55%

5.530

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.